Literature DB >> 24439209

Diabetes in South and Central America: an update.

Pablo Aschner1, Carlos Aguilar-Salinas2, Loreto Aguirre3, Laercio Franco4, Juan Jose Gagliardino5, Sylvia Gorban de Lapertosa6, Segundo Seclen7, Mary Vinocour8.   

Abstract

The estimated population of the South and Central America (SACA) Region is 467.6 million and 64% is in the age range of 20-79 years but the population pyramid and age distribution are changing. The average prevalence of diabetes in the Region is 8.0% and is expected to reach 9.8% by the year 2035. Prevalence is much lower in rural settings than in urban and the differences attributed to lifestyle changes may be a target for intervention. The indigenous population is a particularly vulnerable group needing special attention. On average, 24% of the adult cases with diabetes are undiagnosed but in some countries this is still as high as 50%. Health expenditure due to diabetes in the Region is around 9% of the global total. Inadequate glycemic control, defined as HbA1c >7%, is a strong predictor of chronic complications which increase resource use in the Region and less than half of the patients enrolled in diabetes care programmes are at target. Fifty percent or more of the adult population is overweight/obese and around one third of the adult population has metabolic syndrome using regional cutoffs for waist circumference. The number of people with IGT is almost equal to those with diabetes presenting an additional challenge for prevention. Children with type 1 diabetes represent only 0.2% of the total population with diabetes but the incidence may be increasing. In many places they have limited access to insulin, and even when available, it is not used appropriately. The available epidemiological data provide the background to act in developing national diabetes programmes which integrate diabetes care with cardiovascular prevention and promote diabetes prevention as well.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes; Glycemic control; HbA1c; Impaired Glucose Tolerance; Prevalance; South and Central America

Mesh:

Substances:

Year:  2013        PMID: 24439209     DOI: 10.1016/j.diabres.2013.11.010

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  18 in total

1.  FINDRISC Modified for Latin America as a Screening Tool for Persons with Impaired Glucose Metabolism in Ciudad Bolívar, Venezuela.

Authors:  María Carolina Muñoz-González; Marcos M Lima-Martínez; Aura Nava; Gisuardo Trerotola; Mariela Paoli; Julio O Cabrera-Rego; Briggytte Gonzalez; Amilcairy Arciniegas; Javier Paez
Journal:  Med Princ Pract       Date:  2019-03-11       Impact factor: 1.927

2.  Obese first-degree relatives of patients with type 2 diabetes with elevated triglyceride levels exhibit increased β-cell function.

Authors:  Enrique Torres-Rasgado; Leonardo M Porchia; Guadalupe Ruiz-Vivanco; M Elba Gonzalez-Mejia; Blanca G Báez-Duarte; Patricia Pulido-Pérez; Alicia Rivera; Jose R Romero; Ricardo Pérez-Fuentes
Journal:  Metab Syndr Relat Disord       Date:  2014-11-25       Impact factor: 1.894

Review 3.  Onychomycosis in Patients with Diabetes Mellitus in Africa: A Global Scoping Review, 2000-2021.

Authors:  Bassey E Ekeng; Winnie Kibone; Asa E Itam-Eyo; Felix Bongomin
Journal:  Mycopathologia       Date:  2022-09-03       Impact factor: 3.785

4.  Sex Differences in Diabetes Mellitus Mortality Trends in Brazil, 1980-2012.

Authors:  Thainá Alves Malhão; Alexandre Dos Santos Brito; Rejane Sobrino Pinheiro; Cristiane da Silva Cabral; Thais Medina Coeli Rochel de Camargo; Claudia Medina Coeli
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

5.  Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.

Authors:  Matthew J O'Brien; Ji Young Lee; Mercedes R Carnethon; Ronald T Ackermann; Maria C Vargas; Andrew Hamilton; Nivedita Mohanty; Sarah S Rittner; Jessica N Park; Amro Hassan; David R Buchanan; Lei Liu; Joseph Feinglass
Journal:  PLoS Med       Date:  2016-07-12       Impact factor: 11.069

6.  Prevalence of diabetes and impaired fasting glucose in Peru: report from PERUDIAB, a national urban population-based longitudinal study.

Authors:  Segundo N Seclen; Moises E Rosas; Arturo J Arias; Ernesto Huayta; Cecilia A Medina
Journal:  BMJ Open Diabetes Res Care       Date:  2015-10-19

7.  Metabolic control in patients with type 2 diabetes mellitus in a public hospital in Peru: a cross-sectional study in a low-middle income country.

Authors:  Irma Elizabeth Huayanay-Espinoza; Felix Guerra-Castañon; María Lazo-Porras; Ana Castaneda-Guarderas; Nimmy Josephine Thomas; Ana-Lucia Garcia-Guarniz; Augusto A Valdivia-Bustamante; Germán Málaga
Journal:  PeerJ       Date:  2016-10-13       Impact factor: 2.984

8.  Implementation and Outcomes of a Comprehensive Type 2 Diabetes Program in Rural Guatemala.

Authors:  David Flood; Sandy Mux; Boris Martinez; Pablo García; Kate Douglas; Vera Goldberg; Waleska Lopez; Peter Rohloff
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

Review 9.  From Sea to Shining Sea and the Great Plains to Patagonia: A Review on Current Knowledge of Diabetes Mellitus in Hispanics/Latinos in the US and Latin America.

Authors:  M Larissa Avilés-Santa; Uriyoán Colón-Ramos; Nangel M Lindberg; Josiemer Mattei; Francisco J Pasquel; Cynthia M Pérez
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-10       Impact factor: 5.555

10.  Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis.

Authors:  Shanshan Song; Baosheng Wang; Xin Zhang; Liliang Hao; Xianliang Hu; Zhongxiang Li; Shaolong Sun
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.